fbiop: the income statement

MyFinsight

Fortress Biotech, Inc. (FBIOP)

For the quarter ending 2025-06-30, FBIOP made $16,413K in revenue. $15,486K in net income. Net profit margin of 94.35%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Net revenue	16,413
Selling, general and administrative	38,757
Research and development	8,126
Cost of goods - (excluding amortization of acquired intangible assets)	4,939
Amortization of acquired intangible assets	1,064
Total operating expenses	52,886
Loss from operations	-36,473
Other income (expense)	-62
Interest income	622
Gain from deconsolidation of subsidiary	27,127
Interest expense and financing fee	2,518
Gain (loss) on common stock warrant liabilities	-350
Total other income (expense)	24,819
Net loss	-11,654
Attributable to non-controlling interests	-27,140
Net income (loss) attributable to fortress	15,486

Earnings per share, basic	0.5
Earnings per share, diluted	0.45
Weighted average number of shares outstanding, basic	26,879,380
Weighted average number of shares outstanding, diluted	29,824,182

Unit: Thousand (K) dollars (except for numbers of shares and EPS)